Is MKL a good stock to buy? We came across a bullish thesis on Markel Group Inc. on Casteleyn Partnership’s Substack. In this article, we will summarize the bulls’ thesis on MKL. Markel Group Inc.’s share was trading at $1,979.65 as of July 2nd. MKL’s trailing and forward P/E were 13.86 and 16.31 respectively according to Yahoo Finance.
Copyright: convisum / 123RF Stock Photo
Markel Group Inc. engages in the insurance business in the United States and internationally. MKL is presented as a long-term compounding insurer and investment holding company whose recent quarter reinforces its disciplined underwriting and capital allocation model. The company’s insurance operations continue to be the primary earnings engine, with operating profit rising meaningfully as the combined ratio improved to 92.8% from 96.0%, reflecting tighter underwriting discipline rather than volume chasing.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
International insurance delivered strong growth, while U.S. specialty lines deliberately reduced exposure to lower-quality risks, improving profitability across segments. Programs and solutions continued transitioning toward a lower-risk fronting model, while legacy reinsurance runoff remains a controlled drag rather than a structural concern. Beyond insurance, Markel Ventures showed mixed but resilient performance, with industrial and consumer segments experiencing cyclical pressure offset by long-term compounding potential, while financial services were impacted by one-off items.
Investment income remains a stable recurring engine at roughly $1 billion annually, supported by improving fixed income yields, although GAAP equity volatility created short-term losses that do not reflect underlying economics. Capital allocation remains a core strength, with management prioritizing share repurchases at scale given limited M&A opportunities, reinforcing per-share value accretion.
With intrinsic value estimated around $2,600 per share, the stock is viewed as meaningfully undervalued, offering attractive upside as underwriting improvements, float expansion, and disciplined buybacks compound over time. Overall, Markel is positioned as a high-quality compounder leveraging insurance float, conservative underwriting, and patient capital deployment to drive durable long-term shareholder value creation and compounding earnings power through disciplined leadership and long-duration capital allocation across market cycles over time.
Previously, we covered a bullish thesis on Markel Group Inc. (MKL) by Value Don’t Lie in May 2025, which highlighted the company’s undervaluation, activist-driven value creation, and Markel Ventures’ long-term potential. MKL’s stock price has appreciated by approximately 9.17% since our coverage. Casteleyn Partnership shares a similar view but emphasizes on improving underwriting discipline and disciplined capital allocation driving long-term compounding.
Markel Group Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 53 hedge fund portfolios held MKL at the end of the first quarter which was 43 in the previous quarter. While we acknowledge the risk and potential of MKL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MKL and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
